MONROVIA, Calif., May 1, 2014 /PRNewswire/ -- STAAR Surgical Company (NASDAQ: STAA) a leading developer, manufacturer and marketer of implantable lenses and delivery systems for the eye, today announced that management expects to participate in the following investor conferences:
The 39th Annual Deutsche Bank Health Care Conference at the InterContinental Boston Hotel on Wednesday,May 7 at 12:30 p.m. PT/3:30 p.m. ET
The Bank of America Merrill Lynch Health Care Conference at the Encore at Wynn Las Vegas on Thursday, May 15 at 11:20 a.m. PT/2:20 p.m. ET
Barry Caldwell, President and CEO, and Steve Brown, CFO will offer a general overview of the Company's current business trends, recent financial results, and operational developments. A live webcast, including accompanying slides, will be available from the Company's website, under Investor Information. An archived replay of management's presentations will be available for 90 days following the event, also at www.staar.com.
About STAAR Surgical
STAAR, which has been dedicated solely to ophthalmic surgery for over 25 years, designs, develops, manufactures and markets implantable lenses for the eye and delivery systems therefor. All of these lenses are foldable, which permits the surgeon to insert them through a small incision. STAAR's lens used in refractive surgery as an alternative to LASIK is called an Implantable Collamer® Lens or "ICL." A lens used to replace the natural lens after cataract surgery is called an intraocular lens or "IOL." More than 425,000 Visian ICLs have been implanted to date; to learn more about the ICL go to: www.visianinfo.com. STAAR has approximately 335 full time employees and markets lenses in over 60 countries. Headquartered in Monrovia, CA, it manufactures in the following locations: Nidau, Switzerland; Aliso Viejo, CA; and Monrovia, CA. For more information, please visit the Company's website at www.staar.com.
Doug Sherk, 415-652-9100
Leigh Salvo, 415-568-9348
SOURCE STAAR Surgical Company